|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,766.00 GBX | -1.02% |
|
-2.96% | +7.08% |
| 04-15 | European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading | MT |
| 04-15 | London's FTSE 100 flat as banks limit healthcare gains; Mideast in focus | RE |
| Capitalization | 311B 263B 243B 229B 427B 28,983B 434B 2,848B 1,115B 13,915B 1,167B 1,142B 49,406B | P/E ratio 2026 * |
25.3x | P/E ratio 2027 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise value | 330B 279B 258B 243B 453B 30,750B 460B 3,022B 1,183B 14,763B 1,238B 1,212B 52,417B | EV / Sales 2026 * |
5.22x | EV / Sales 2027 * | 4.8x |
| Free-Float |
96.62% | Yield 2026 * |
1.66% | Yield 2027 * | 1.76% |
Last Transcript: AstraZeneca PLC
| 1 day | -1.02% | ||
| 1 week | -2.96% | ||
| Current month | +0.52% | ||
| 1 month | +2.68% | ||
| 3 months | +5.28% | ||
| 6 months | +16.78% | ||
| Current year | +7.08% |
| 1 week | 14,765.11 | 15,450 | |
| 1 month | 13,478 | 15,450 | |
| Current year | 13,268 | 15,732 | |
| 1 year | 9,651 | 15,732 | |
| 3 years | 9,461 | 15,732 | |
| 5 years | 7,301 | 15,732 | |
| 10 years | 3,680 | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 65 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Sharon Barr
CTO | Chief Tech/Sci/R&D Officer | - | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 65 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.02% | -2.96% | +43.64% | +24.17% | 311B | ||
| -1.89% | -5.06% | +19.53% | +141.52% | 810B | ||
| -0.60% | -1.09% | +55.36% | +43.92% | 575B | ||
| -0.05% | -1.50% | +17.88% | +28.98% | 369B | ||
| -0.35% | +0.48% | +23.57% | +13.94% | 324B | ||
| -1.72% | -4.29% | +50.40% | +2.25% | 291B | ||
| -1.61% | -2.34% | +31.20% | +35.32% | 289B | ||
| -0.78% | -0.45% | +17.92% | +39.29% | 188B | ||
| -0.48% | -1.25% | +32.26% | +68.40% | 173B | ||
| +2.32% | +4.89% | -40.83% | -55.99% | 176B | ||
| Average | -0.45% | -1.06% | +25.09% | +34.18% | 350.69B | |
| Weighted average by Cap. | -0.36% | -1.28% | +28.77% | +52.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.18B 53.52B 49.35B 46.54B 86.8B 5,890B 88.2B 579B 227B 2,828B 237B 232B 10,040B | 67.07B 56.82B 52.39B 49.4B 92.14B 6,252B 93.63B 614B 241B 3,002B 252B 246B 10,658B |
| Net income | 12.5B 10.59B 9.76B 9.21B 17.17B 1,165B 17.45B 115B 44.82B 559B 46.9B 45.91B 1,986B | 14.11B 11.95B 11.02B 10.39B 19.39B 1,315B 19.7B 129B 50.6B 632B 52.95B 51.84B 2,242B |
| Net Debt | 18.95B 16.05B 14.8B 13.96B 26.03B 1,766B 26.45B 174B 67.95B 848B 71.1B 69.61B 3,011B | 11.01B 9.33B 8.6B 8.11B 15.13B 1,026B 15.37B 101B 39.48B 493B 41.31B 40.44B 1,749B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-15 | 14,766.00 p | -1.02% | 2,164,921 |
| 26-04-14 | 14,918.00 p | -0.47% | 1,318,293 |
| 26-04-13 | 14,988.00 p | -1.59% | 1,951,201 |
| 26-04-10 | 15,230.00 p | -0.30% | 2,342,633 |
| 26-04-09 | 15,276.00 p | +0.39% | 2,694,111 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















